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Abstract 
 
Background: Bone healing and its reconstruction in fractures, especially in long bones are of particular im-
portance in regenerative medicine. This study compares the bone healing rate after a human xenograft of miner-
alized bone and together with an allograft of bone marrow mesenchymal stem cells (MSCs) in an experimental 
tibial bone fracture rabbit model.  
 
Methods: In fall 2009, twenty New Zealand white rabbits were randomly divided into 2 equal groups. In both 
groups, a 5 mm segmental defect was created in the right tibia. In group A, a scaffold pin was seeded with allo-
genic rabbit MSCs and was placed in the defect area and in group B, the defect was filled with an unseeded pin 
human mineralized bone xenograft. An untreated defect was induced in the left tibia of all animals serving as the 
control. After 4-8 weeks, the segmental defects were histologically evaluated and also by a compressive test.  
 
Results: In groups A and B, healing and formation of new bony tissue were significantly more than the control 
group and with a significant less inflammation.  
 
Conclusion: Tissue engineering of mineralized bone xenograft and MSCs allograft may be significant steps in 
bone healing and regenerative medicine. 
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Introduction 
 
Bone as part of skeletal system is responsible for me-
chanical support, body shape and movement. In addi-
tion, its role in mineral homeostasis and in energy 
metabolism was previously shown.
1 An autologous 
bone graft is used in patients with large bone defects 
but still is not easily available for about 40% of sub-
jects.
2 Healing in large bone defects using adult stem 
cells together with ceramic scaffolds is a today need; 
but the biological mechanisms in this relation are not 
still completely clear.
3 In case of damage in bone in-
tegrity (e.g. after fracture), mesenchymal stem cells 
(MSCs) play an important role in tissue engineering. 
MSCs are multipotent cells of mesodermal origin ca-
pable of differentiating into osteoblasts, chondro-
cytes, adipocytes, tenocytes and myoblasts.
4,5 Apart 
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from bone marrow, they are found in endosteum of 
the trabecular bone, and the periosteum too.
6 Some of 
cytokines released from the damaged bone matrix and 
from degranulated thrombocytes result into formation 
of a mixture of biologically active protein that can af-
fect MSCs chemotactically. MSCs derived from peri-
osteum and bone marrow when transferred to the site 
of bone damage, they continue to multiply and differ-
entiate into osteoblastic, chondroblastic and fibro-
blastic cell lines
7 and participate in production of bone 
and cartilage tissues that form a callus at the fracture 
site.
8,9  
Fixation of the fracture site has an important role 
in repair of bony tissue. The under-load bone frag-
ments may experience certain motions by unknown 
mechanisms affecting the morphologic features of 
repair in the fracture site.
10 Intra-medullary pinning 
has been previously used in fixation of bony tissue in 
small animals.
11 MSCs are the most used cell types in 
tissue engineering of bony tissue, both in vivo and in 
vitro.
3 These cells can be easily isolated from bone mar-
row and expanded through several passages while re-
taining their multipotent differentiation capacity. Low-
immunogenicity of MSCs both in vitro and in vivo, 
suggest their utility for autologous as well as allogeneic 
transplantations. Besides their differentiation capabili-
ties, MSCs take part in matrix remodeling and possess 
paracrine activities particularly in the microenvironment 
of a wound.
2 Therefore, in use of MSCs, a number of 
osteoinductive carriers have been tested based on syn-
thetic polymers, DBM, hydrogel, titanic fibers, natural 
coral and synthetic bioceramics based on hydroxyapatite 
and tricalcium phosphate.
12-14 
In this study, the bone healing rate after a tissue 
engineering technique of bone xenograft scaffolds 
from human bone is compared with an allograft of 
bone marrow derived MSCs in an experimental tibial 
fracture rabbit model. 
 
 
Materials and Methods 
 
In fall 2009, twenty 6 months old male New Zealand 
white rabbits weighing 2.5 kg provided from Labora-
tory Animal Center of Shiraz University of Medical 
Sciences were divided into 2 equal groups. In both 
groups, a 5 mm segmental defect was induced in the 
right tibia. To compare the healing rate of the defect 
in the right tibia, in group A, a scaffold pin was seed-
ed with allogenic rabbit MSCs and was implanted in 
the defective area. In group B, the defect was filled 
with just a human mineralized bone xenograft (un-
seeded pin). For control group, in the left tibia of all 
animals, an identical defect was induced without any 
treatment.  
Animal selection, all experiments, subsequent care 
and the sacrifice procedures were all adhered to the 
guidelines and were under the supervision of the Animal 
Care Committee of Iran Veterinary Organization. The 
study was approved by the Ethics Committee of Tehran 
University of Medical Sciences. The animals were kept 
individually in one cage in an ambient temperature of 
21±2°C and a 65-70% relative humidity. They were fed 
with a balanced diet and had free access to water and 
had a free mobilization condition.  
The scaffold was a human bone fragment with a 
size of 1x1x30 mm provided from human femoral 
bone with a compact and cortical surface and parallel 
grooves that were used for cell seeding. These frag-
ments were sterilized by C0-60 γ-rays before use. The 
scaffold pin was seeded with cells cultured for 3 days 
in the media. 
A compressive test with a rate of 1.0 mm/min was 
applied for the bone scaffolds (Santam STM-20) and 
the load and displacement data were recorded in the 
computer to provide the stress-strain curves and to 
determine the compressive strength and stiffness of 
the scaffolds. The breaking load was obtained from 
the slope of the curve. Bending modulus (e) and 
strength (δ) were determined using δ=3FL/2bd
2 and 
e=L3F/4wh
3d formulas.  
Under general anesthesia, the bone marrow was 
derived from the iliac crest using a 3 mm in diameter 
of sterile bone marrow aspiration needle. After touch-
ing the marrow space and removing the trocar, bone 
marrow was aspirated using a 2 ml syringe containing 
0.1 ml heparin. The aspirated marrow was mixed in a 
15 ml falcon tube (Nunc, Germany) containing 5 ml 
of DMEM (Gibco, USA) and 4 mm ficol (General, 
Netherland). The marrow aspirate was then homoge-
nized with a pipette, then plated in a T75 culture flask 
(Nunc, Germany) containing DMEM (Gibco, USA)   
and 10% FBS (Bio-sera, UK) after they were centri-
fuged at 2000 rpm for 20 min (Hettich Universal 320 
R , Germany). After 24 h, non-adhesive cells (hema-
topoietic cells) were eliminated by medium change 
and the adhesive cells were washed once with PBS 
(Gibco, USA) and incubated at 37°C and 5% CO2. 
The medium was changed twice a week. Adherent 
spindle-shaped cells were obtained from the primary 
culture after 3 passages. At 80-90% confluence, cells 
were harvested with trypsin/EDTA (Bio-Sera, UK) Ai et al. 
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and replated by splitting, usually 1:3 at a density of 
50–60%. Cells of 3
rd passage were analyzed by flow-
cytometry using MSCs with typical cell surface 
markers including CD90, CD130, CD34 and CD45 
(Stem cell, UK). 
Bone scaffolds (pin) were preserved for 2 h in 
DMEM medium. 1x10
6  cells from the 3
rd passage 
were resuspended in the medium. The cell suspension 
was added to the pin using a 26-gauge needle to inject 
1 ml until the scaffold material was soaked complete-
ly in the suspension. The pin was then placed in an 
incubator at 37°C for 4 h. Subsequently, the respec-
tive media were added and the pin was incubated at 
37°C in 5% CO2. They were rinsed twice with PBS, 
fixed in 2.5% glutaraldehyde in 0.1 M phosphate 
buffer for 2 h and prepared for scanning electron mi-
croscopy (SEM) (Philips XL30, Japan) to determine 
the cell adhesion and penetration. The scaffold pin 
was implanted after 3 days of culture with allogenic 
rabbit MSCs. 
A unilateral 5 mm defect was created in the mid-
dle part of the tibia. The rabbits were anesthetized by 
intramuscular injection of ketamine hydrochloride (50 
mg/kg, Unitech, Germany) and xylazine (5 mg/kg, 
Unitech, Germany). An antibiotic (4 mg/kg, Razi, 
Iran) was supplied preoperatively. Following a 3 cm 
supramedial incision over the distal tibia, the soft tis-
sues were dissected and the bone was exposed after 
gentle retraction of the muscles. A 5 mm segmental 
tibial defect in the right and left tibias of the rabbits 
were created under irrigation with 0.9% sterile saline 
solution. Created defects in the right tibias were used 
for treatment groups and the left tibias were used as 
control group. The periosteum was removed with the 
bone, and 5 ml of periosteum was deprived from each 
side of the remaining tibia. The gap was irrigated 
with sterile physiological saline solution and in group 
A, the pin and MSCs or in group B, the pin only filled 
the gap. For fixation of these segmental defects in 
groups A and B and the control group, a ligature wire 
was applied. Muscles, fascia and skin were separately 
closed over the defect with 4–0 resorbable sutures 
(Norderstedt, Germany) (Figure 1). After 4 weeks, 
five animals and after 8 weeks, 5 more animals were 
sacrificed from each group and their tibia were re-
moved and fixed in 10% formalin for one week for 
histological analysis. 
Formalin-fixed samples were decalcified in 10% 
nitric acid for one week, then dehydrated in an etha-
nol series and embedded in paraffin using standard 
histological techniques. Five-micrometer serial sec-
tions were cut. Sections were stained with hematoxylin  
 
 
Fig. 1: Transplantation of pin seeded with MSCs into 
segmental tibia defect fixed with ligature wire in rab-
bit model. 
 
and eosin (H & E) to identify any inflammatory re-
sponse based on infiltration of lymphocytes around 
the defective site as described by Tanaka et al.
15 
Data analysis was performed with SPSS software 
(Version 14.0, Chicago, IL, USA). Data were pre-
sented as the mean±standard error of the mean 
(SEM). Statistical comparisons were made by one 
way ANOVA and when significant differences were 
observed, Tukey test was employed for multiple 
comparisons. Statistical significance was considered 
at p<0.05. 
 
 
Results 
 
Formation of new bony and vascular tissues was visi-
ble adjacent to the scaffold pin edge 4 weeks post-
implantation. Four weeks post-implantation, all ani-
mals in group A treated with pin and in group B treat-
ed with pin and MSC showed a fully recovered motor 
response. The implanted scaffolds degraded clearly 
and were replaced by newly formed bony and carti-
lage tissues. Many cells, such as chondrocytes and 
osteocytes were noticed in the implantation site. New 
bony tissue was present within the marrow cavity. 
The new bony tissue in the defective region had com-
pletely been remodeled.  
MSCs derived from bone marrow had a similar 
spindle-shaped morphology which were negative for 
hematopoietic (CD34, CD45) and positive for mesen-Tissue engineering in bone regeneration 
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chymal markers (CD13, CD90). Results for flowcy-
tometry analysis were shown after 3 days of cell   
seeding and SEM observations showed the presence 
of MSCs on the scaffold (Figures 2-4). The compres-
sion breaking load for scaffold was 157.5 N; and for 
compressive modulus and compressive strength were 
2493.6 MPa and 15.74 MPa respectively (Figure 5A). 
The compression breaking load for scaffold bending 
test was 78.28 N; and for bending modulus and bend-
ing strength were 58.5 MPa and 3510 MPa respec-
tively (Figure 5B). 
 
 
 
Fig. 2: Microscopic view of bone marrow-derived mes-
enchymal cells in the primary culture (40x). 
In group A, after 4 weeks, 34.8% of the entire defec-
tive area was filled with new bony tissue confirmed his-
tologically. In group B, 30% of the defects were re-
placed with new bony tissue and in the control group 
10% were filled with new bony tissue. The new bony 
tissue formed in group A was more than group B but the 
difference was not statistically significant. In both 
groups, the difference was significant in comparison to 
the control group (p=0.001). 
In group A after 8 weeks, 89.5% of the defects 
were filled with new bony tissue. This figure for 
group B and the control group was 83.9% and 20% 
respectively. The difference was statistical significant 
between groups A and B and between these groups 
and the control group (p=0.001). Table 1 and Figure 6 
and 7 illustrate the histological findings of new bony 
tissue formed in the three groups. 
After 4 weeks, inflammation was just visible in 
13.9% of group A and 14.3% of group B in compari-
son to 71% of the control group showing a healing 
trend in groups A and B but the difference between 
groups A and B was not statistically significant 
(p>0.05) (Figure 7). The difference was statistically 
significant between groups A and B and the control 
group (p=0.001). After 8 weeks, there were no in-
flammation visible in the both A and B groups in   
 
 
Fig. 3: Flow-cytometry analysis of the rabbit bone marrow adherent cells after 3 passages. Ai et al. 
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Fig. 4: SEM micrograph of pin seeded with MSCs after 3 days of culture in vitro. a) SEM image of the pin surface 
(bar=1 mm); b) MSCs were seeded on the surface of the pin (bar=100 μm); c) A colony from MSCs on the surface 
of the pin (bar=20 μm); d) Parallel grooves and colonies from MSCs on the surface of the pin (bar=10 μm). 
 
 
Fig. 5: A. The results of compressive test for pin. B. The results of compressive test for pin bending test. Data were 
automatically recorded and stored in a computer. Tissue engineering in bone regeneration 
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Table 1: Osteogenesis after use of pin and pin together with MSCs after 4-8 weeks post-implantation 
in comparison to the control group using histological analysis (mean±SEM; n=5 in each group). 
Osteogenesis (New bone formation %)
Experimental group  After 4 weeks After 8 weeks 
Pin 
Pin and MSCs 
Control 
30.06±0.9357 
34.86±2.002 
10.49±0.3731 
83.96±1.450 
89.56±1.481 
20.19±0.5324 
 
 
 
 
Fig. 6: Photomicrographs of H&E stained histological sections from bone defect. A. New bone tissue and few 
vascular cavities were formed adjacent to the pin edge after 4 weeks post-implantation. B. After 8 weeks, defects 
grafted with pin and pin together with MSCs could almost be completely filled with new bony tissue. Bony tissue 
formed in internal side of the defect was completely remodeled. A new bone was present within the marrow cavi-
ty that was initially filled with bony tissue (x40) C. Gross appearance of the control group. D, E. The control group 
after 4 and 8 weeks post-implantation which was primarily filled with less connective tissue and showed the min-
imal new bone formation (x10). H: The fracture site, N (nb): New bone, P: Pin, B: Bone marrow, V: vascular cavi-
ty, CT: connective tissue, Hb: host bone. 
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Fig. 7: Comparison of the measure of new bone formation quantified by histomorphometric analysis in groups 
which showed evidence of osteogenesis following 4 and 8 weeks post implantation as compared to control group. Ai et al. 
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comparison to the control group (p=0.001) (Table 2, 
Figure 8) showing a healing trend in groups A and B. 
The scaffold bending test for the bending modulus 
and strength was as follows: d=1 mm, h=1 mm, b=1 
mm, L=30 mm, W=30, F=78 N, δ=3FL/2bd
2= 
3510Mpa and e=L3F/4wh
3d=58.5MPa 
 
 
Discussion  
 
The repair of bone defects by using stem cells is still a 
major challenge in tissue engineering.
16-18 Bone mar-
row-derived MSCs promote bone repair when implant-
ed locally, usually on a scaffold such as hydroxyap-
atite/tricalcium phosphate or hydroxyapatite ceramic. 
In the case of long bone defects, a porous ceramic 
scaffold together with MSCs was shown to complete 
unification between implant and bone after a 5-6 
months period.
9,13,19 Peterson et al. also showed that a 
collagen-ceramic carrier seeded with MSCs derived 
from human adipose tissue could be implanted into 
large femoral bone defects of rats and after 8 weeks 
could promote the healing.
20 The   
scaffold used in this study was originated from hu-
man femoral bone which was used together with 
MSCs and their ability in the regeneration of bony 
tissue was evaluated. The results revealed that MSCs 
played a crucial role in repair of bone defects. Our 
data demonstrated that new bone formation and step 
of maturity were significantly more, when the scaffold 
was used with MSCs. Considering inflammation, bet-
ter results were observed in groups using pin alone and 
pin together with MSCs in comparison to the control 
group, but no statistical difference was noticed be-
tween unloaded scaffolds and those scaffolds loaded 
with MSCs. The histological evaluation to determine 
the biodegradation of the scaffolds showed a faster 
resorption of pin in both groups using pin alone and 
pin together with MSCs after 8 weeks.  
It was shown that bone tissue derived from human 
MSCs was at the center of transplants, but not at the 
periphery.
21 Bone tissue at the periphery and the bone 
marrow were identified as a host origin.
21 However, 
in our study in both groups, new bone formation was 
noticed in the periphery and center of transplants, but 
in the control group, less new bone formation was 
detected at the periphery. These data suggest that 
new bone formation is limited by the availability of 
Table 2: Degree of inflammation in pin and  pin together with MSCs after 4-8 weeks post-implantation 
in comparison to the control group using histological analysis (mean±SEM; n=5 in each group) 
Degree of inflammation (%) 
Experimental group  After 4 weeks After 8 weeks 
Pin 
Pin and MSCs 
control 
14.38±0.7921 
13.94±0.7514 
71.2±0. 9638 
0 
0 
45.5±0.2587 
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Fig. 8: Comparison of inflammation quantified by histomorphometric analysis in groups which showed evidence of a 
decrease in inflammation following 4 and 8 weeks post implantation as compared to control group. The error bar 
indicate SE for n=5, p value <0.001 are indicated by ***.  Tissue engineering in bone regeneration 
 
WWW.ircmj.com Vol 14 February 2012  103
recipient-derived bone forming cells. Rudimentary 
results of this study regarding a better healing rate in 
bone defects appear promising. Investigation of the 
regenerative potential of transplanted pin together 
with MSCs in animal model was a first step in ther-
apeutic application of this pin together with MSCs in 
the clinical practice. Therefore, tissue engineering of 
mineralized bone xenograft and MSCs allograft may 
be significant steps in bone healing and regenerative 
medicine.  
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